Personal Capital Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$232K	Sell	2,796 -1,216	-30%	-$98.4K	﹤0.01%	432
2022 Q3	$318K	Buy	4,012 +276	+7%	+$23.3K	﹤0.01%	350
2022 Q2	$277K	Buy	3,736 +246	+7%	+$18.5K	﹤0.01%	369
2022 Q1	$314K	Sell	3,490 -356	-9%	-$32.9K	﹤0.01%	381
2021 Q4	$431K	Sell	3,846 -75	-2%	-$9.05K	﹤0.01%	366
2021 Q3	$493K	Buy	3,921 +110	+3%	+$14.2K	﹤0.01%	311
2021 Q2	$516K	Sell	3,811 -306	-7%	-$40.2K	﹤0.01%	304
2021 Q1	$558K	Buy	4,117 +1,666	+68%	+$249K	﹤0.01%	293
2020 Q4	$345K	Sell	2,451 -282	-10%	-$36.1K	﹤0.01%	354
2020 Q3	$305K	Buy	2,733 +188	+7%	+$21.1K	﹤0.01%	327
2020 Q2	$285K	Buy	+2,545	New	+$251K	﹤0.01%	297
2020 Q1	–	Sell	-2,408	Closed	-$229K	–	410
2019 Q4	$229K	Buy	+2,408	New	+$208K	﹤0.01%	372